![]() Pacific Biosciences of California Pacific Biosciences of California (PacBio, formerly known as Nanofluidics) is a company developing a platform for genetic analysis. | ![]() Roche Roche Holding is the holding company of F. Hoffmann-La Roche, a biotech company operating through 2 segments: Pharmaceuticals and Diagnostics. | ![]() Thermo Fisher Scientific Thermo Fisher Scientific is a global provider of laboratory products and services, life science solutions, analytical instruments, and specialty diagnostics. | ![]() Illumina Illumina is a company that develops, manufactures, and markets sequencing- and array-based integrated systems for genetic and genomic analysis. | ![]() Oxford Nanopore Technologies Oxford Nanopore Technologies is a company that develops nanopore-based electronic systems for the analysis of single molecules. | |||
Founding Date | Founding Date 2004 | Founding Date 2011 | Founding Date 1896 | Founding Date 1984 | Founding Date 1956 | Founding Date 1998 | Founding Date 2005 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||||
Locations | Locations Menlo Park, US HQ Shanghai, CN Yokohama, JP Seoul, KR Singapore, SG London, GB Baltimore, US see more | Locations Menlo Park, US HQ Shanghai, CN West Wickham, GB | Locations Venlo, NL HQ Chadstone, AU Antwerpen, BE São Paulo, BR Toronto, CA Shanghai, CN Shenzhen, CN see more | Locations Waltham, US HQ Buenos Aires, AR Buenos Aires, AR Buenos Aires, AR Adelaide Airport, AU Brendale, AU Canberra, AU see more | Locations San Diego, US HQ Melbourne, AU Sao Paulo, BR Beijing, CN Shanghai, CN évry Courcouronnes, FR Berlin, DE see more | ||
Employees | Employees 72877% increase | Employees 32538% increase | Employees 100,9201% decrease | Employees 6,0287% increase | Employees 130,00063% increase | Employees 9,10017% increase | Employees 70551% increase |
Valuation ($) | Valuation ($) 2.6 b | Valuation ($) 106.6 m | Valuation ($) N/A | Valuation ($) 11.1 b | Valuation ($) 226 b | Valuation ($) 33.5 b | Valuation ($) 2.5 b |
Twitter followers | Twitter followers 42.4 k | Twitter followers 3 k | Twitter followers 247.4 k | Twitter followers 16.6 k | Twitter followers 65.7 k | Twitter followers 99.8 k | Twitter followers 59.4 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 120 | Number of tweets (last 30 days) 10 | Number of tweets (last 30 days) 29 | Number of tweets (last 30 days) 8 | Number of tweets (last 30 days) 16 | Number of tweets (last 30 days) 25 | Number of tweets (last 30 days) 207 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 5.4 | Average likes per tweet (last 30 days) 4.4 | Average likes per tweet (last 30 days) 5.2 | Average likes per tweet (last 30 days) 2.5 | Average likes per tweet (last 30 days) 11.3 | Average likes per tweet (last 30 days) 9.1 | Average likes per tweet (last 30 days) 8.4 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 97.5% | Percentage of tweets with engagement (last 30 days) 80% | Percentage of tweets with engagement (last 30 days) 62.07% | Percentage of tweets with engagement (last 30 days) 62.5% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 92% | Percentage of tweets with engagement (last 30 days) 98.07% |
Alexa Website Rank | Alexa Website Rank 515412 | Alexa Website Rank 599783 | Alexa Website Rank 46160 | Alexa Website Rank 643384 | Alexa Website Rank 11954 | Alexa Website Rank 97803 | Alexa Website Rank 307870 |
Employee Rating | Employee Rating 3.4 | Employee Rating 3.7 | Employee Rating 4.2 | Employee Rating 3.8 | Employee Rating 3.8 | Employee Rating 4.1 | Employee Rating 3.6 |
Financial | |||||||
Revenue (est.) | Revenue (est.) $130.5m (FY, 2021) | Revenue (est.) $85.5m (FY, 2021) | Revenue (est.) CHF62.8b (FY, 2021) | Revenue (est.) $2.3b (FY, 2021) | Revenue (est.) $39.2b (FY, 2021) | Revenue (est.) $4.5b (FY, 2021) | Revenue (est.) £133.7m (FY, 2021) |
Cost of goods | Cost of goods $71.7m (FY, 2021) | Cost of goods $53.8m (FY, 2021) | Cost of goods (CHF15.5b) (FY, 2021) | Cost of goods $518.6m (FY, 2021) | Cost of goods $19.6b (FY, 2021) | Cost of goods $1.4b (FY, 2021) | Cost of goods £44.9m (FY, 2021) |
Gross profit | Gross profit $58.9m (FY, 2021) | Gross profit $31.7m (FY, 2021) | Gross profit CHF50.4b (FY, 2021) | Gross profit $1.7b (FY, 2021) | Gross profit $19.6b (FY, 2021) | Gross profit $3.2b (FY, 2021) | Gross profit £88.7m (FY, 2021) |
Net income | Net income ($181.2m) (FY, 2021) | Net income ($65.2m) (FY, 2021) | Net income CHF14.9b (FY, 2021) | Net income $537.1m (FY, 2021) | Net income $7.7b (FY, 2021) | Net income $762m (FY, 2021) | Net income (£167.6m) (FY, 2021) |
Operating ⚠ | |||||||
Backlog | Backlog N/A | Backlog N/A | Backlog N/A | Backlog N/A | Backlog $7.8b (FY, 2019) | Backlog $1b (FY, 2022) | Backlog N/A |
Patents (US) | Patents (US) 221 (FY, 2016) | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A | Patents (US) 1 k (FY, 2022) | Patents (US) N/A |
Funding | |||||||
Total funding raised | Total funding raised $ 513.6m | Total funding raised $ 75m | Total funding raised $ 7.8b | Total funding raised $ 4m | Total funding raised $ 500m | Total funding raised $ 28m | Total funding raised $ 1.3b |
Personalis is a company specializing in cancer genomics.
View companyRoche Holding is the holding company of F. Hoffmann-La Roche, a biotech company operating through 2 segments: Pharmaceuticals and Diagnostics.
View companyQiagen is a company that provides a sample to insight solutions for molecular testing.
View companyThermo Fisher Scientific is a global provider of laboratory products and services, life science solutions, analytical instruments, and specialty diagnostics.
View company